DIANA COREA: Open Payments
NPI 1770199788 · CORONA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$297 in 11 payments from 7 companies in 2025. Trend: 2023 $217 · 2024 $173 · 2025 $297
Food & beverage: $297
| Company | Payments | Amount |
|---|---|---|
| Globus Medical, Inc. | 3 | $130 |
| IBSA Pharma Inc. | 3 | $54 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $34 |
| Averitas Pharma Inc. | 1 | $26 |
| Curonix LLC | 1 | $23 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
| SPR Therapeutics, Inc | 1 | $13 |
Products named: Senza, Tirosint, JOURNAVX, QUTENZA, PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A, XTAMPZA, SPRINT PNS System.
Industry payments across CA — which companies pay providers there.
